BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 19963129)

  • 1. Genomic deletions at 1p and 14q are associated with an abnormal cDNA microarray gene expression pattern in meningiomas but not in schwannomas.
    Martínez-Glez V; Alvarez L; Franco-Hernández C; Torres-Martin M; de Campos JM; Isla A; Vaquero J; Lassaletta L; Castresana JS; Casartelli C; Rey JA
    Cancer Genet Cytogenet; 2010 Jan; 196(1):1-6. PubMed ID: 19963129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meningiomas and schwannomas: molecular subgroup classification found by expression arrays.
    Martinez-Glez V; Franco-Hernandez C; Alvarez L; De Campos JM; Isla A; Vaquero J; Lassaletta L; Casartelli C; Rey JA
    Int J Oncol; 2009 Feb; 34(2):493-504. PubMed ID: 19148485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas.
    Arslantas A; Artan S; Oner U; Durmaz R; Müslümanoğlu H; Atasoy MA; Başaran N; Tel E
    Acta Neurol Belg; 2002 Jun; 102(2):53-62. PubMed ID: 12161900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-resolution profiling of an 11 Mb segment of human chromosome 22 in sporadic schwannoma using array-CGH.
    Mantripragada KK; Buckley PG; Benetkiewicz M; De Bustos C; Hirvelä C; Jarbo C; Bruder CE; Wensman H; Mathiesen T; Nyberg G; Papi L; Collins VP; Ichimura K; Evans G; Dumanski JP
    Int J Oncol; 2003 Mar; 22(3):615-22. PubMed ID: 12579316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas.
    Leone PE; Bello MJ; de Campos JM; Vaquero J; Sarasa JL; Pestaña A; Rey JA
    Oncogene; 1999 Apr; 18(13):2231-9. PubMed ID: 10327069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelic status of 1p, 14q, and 22q and NF2 gene mutations in sporadic schwannomas.
    Leone PE; Bello MJ; Mendiola M; Kusak ME; De Campos JM; Vaquero J; Sarasa JL; Pestana A; Rey JA
    Int J Mol Med; 1998 May; 1(5):889-92. PubMed ID: 9852312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive DNA copy number profiling of meningioma using a chromosome 1 tiling path microarray identifies novel candidate tumor suppressor loci.
    Buckley PG; Jarbo C; Menzel U; Mathiesen T; Scott C; Gregory SG; Langford CF; Dumanski JP
    Cancer Res; 2005 Apr; 65(7):2653-61. PubMed ID: 15805262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1p and 3p deletions in meningiomas without detectable aberrations of chromosome 22 identified by comparative genomic hybridization.
    Carlson KM; Bruder C; Nordenskjöld M; Dumanski JP
    Genes Chromosomes Cancer; 1997 Dec; 20(4):419-24. PubMed ID: 9408760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression.
    Simon M; von Deimling A; Larson JJ; Wellenreuther R; Kaskel P; Waha A; Warnick RE; Tew JM; Menon AG
    Cancer Res; 1995 Oct; 55(20):4696-701. PubMed ID: 7553651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications.
    Cai DX; Banerjee R; Scheithauer BW; Lohse CM; Kleinschmidt-Demasters BK; Perry A
    J Neuropathol Exp Neurol; 2001 Jun; 60(6):628-36. PubMed ID: 11398839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma.
    Lusis EA; Watson MA; Chicoine MR; Lyman M; Roerig P; Reifenberger G; Gutmann DH; Perry A
    Cancer Res; 2005 Aug; 65(16):7121-6. PubMed ID: 16103061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microarray-based analysis of spinal versus intracranial meningiomas: different clinical, biological, and genetic characteristics associated with distinct patterns of gene expression.
    Sayagués JM; Tabernero MD; Maíllo A; Trelles O; Espinosa AB; Sarasquete ME; Merino M; Rasillo A; Vera JF; Santos-Briz A; de Alava E; Garcia-Macias MC; Orfao A
    J Neuropathol Exp Neurol; 2006 May; 65(5):445-54. PubMed ID: 16772868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas.
    Lamszus K; Kluwe L; Matschke J; Meissner H; Laas R; Westphal M
    Cancer Genet Cytogenet; 1999 Apr; 110(2):103-10. PubMed ID: 10214357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of chromosome 1p and loss of expression of alkaline phosphatase indicate progression of meningiomas.
    Müller P; Henn W; Niedermayer I; Ketter R; Feiden W; Steudel WI; Zang KD; Steilen-Gimbel H
    Clin Cancer Res; 1999 Nov; 5(11):3569-77. PubMed ID: 10589773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular genetics of meningiomas: from basic research to potential clinical applications.
    Simon M; Boström JP; Hartmann C
    Neurosurgery; 2007 May; 60(5):787-98; discussion 787-98. PubMed ID: 17460514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal analysis of human meningiomas and schwannomas.
    Jacoby LB; Pulaski K; Rouleau GA; Martuza RL
    Cancer Res; 1990 Nov; 50(21):6783-6. PubMed ID: 2208143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of chromosome 1p deletion using FISH on meningioma touch imprints suggest a region outside chromosome 22 as important in tumor recurrence.
    Tamiolakis D; Papadopoulos N; Lambropoulou M; Kotini A; Simopoulos C
    Minerva Med; 2003 Feb; 94(1):51-6. PubMed ID: 12719702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetics and molecular genetics of nervous system tumors.
    Rey JA; Pestaña A; Bello MJ
    Oncol Res; 1992; 4(8-9):321-31. PubMed ID: 1336685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative 'tumor progression' locus.
    Menon AG; Rutter JL; von Sattel JP; Synder H; Murdoch C; Blumenfeld A; Martuza RL; von Deimling A; Gusella JF; Houseal TW
    Oncogene; 1997 Feb; 14(5):611-6. PubMed ID: 9053860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for telomeric and centromeric instability in the progression of chromosome aberrations in meningioma patients.
    Sawyer JR; Husain M; Pravdenkova S; Krisht A; Al-Mefty O
    Cancer; 2000 Jan; 88(2):440-53. PubMed ID: 10640979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.